FLGT News and Press, Fulgent Genetics Inc. From 03/05/21

Fulgent Genetics (FLGT) has risen ~27.4% in the premarket after a sizable beat in the Q4 2020 earnings.2020 revenue has increased ~13.0x from the previous year to reach ~$421.7M after the quarterly revenue rose ~35.2x to ~$295.0M. However, non-COVID revenue for Q4 2020 has rise...

Fulgent Genetics (NASDAQ: FLGT) stock absolutely skyrocketed throughout January and early February. But after shares rose more than 250%, Fulgent's momentum seemed to fizzle out. That fizzle is likely to return to a sizzle now, though. The genetic-testing company provided its fo...

Image source: The Motley Fool. Fulgent Genetics, Inc. Common Stock (NASDAQ: FLGT) Q4 2020 Earnings Call Mar 04, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: Fulgent Genetics, Inc. Common Stock (FLGT) Q4 2020 Earn...

Fulgent Genetics, Inc. (FLGT) Q4 2020 Results Conference Call March 4, 2021 4:30 PM ET Company Participants Nicole Borsje - Head of Investor Relations Ming Hsieh - Chief Executive Officer Brandon Perthuis - Chief Commercial Officer Paul Kim - Chief Financial Officer Conference Call Participan...

Fulgent Genetics (FLGT): Q4 Non-GAAP EPS of $6.20 beats by $2.15; GAAP EPS of $6.16 beats by $2.09.Revenue of $294.9M (+3414.9% Y/Y) beats by $95.52M.2021 Outlook:Expects overall revenue of approximately $800.0 million ($600.22M consensus) in 2021, representing growth of 90% year-over-yearOf ...

Fourth Quarter 2020 Results : Record Revenue of $295.0 million, growing more than 3,400% year-over-year Record Billable tests delivered approximately 3.2 million, approximately 230 times the volume of fourth quarter of 2019 Gross Margin improved over 8 percentage points ...

[[AQN]], [[AVGO]], [[CERT]], [[CHUY]], [[COO]], [[COST]], [[FLGT]], [[GPS]], [[GWRE]], [[IMAX]], [[JAMF]], [[MANU]], [[MDLA]], [[OPEN]], [[PLYA]], [[SDC]], [[SWBI]], [[WORK]]For Seeking Alpha's full earnings season calendar, click here. For further details see: Notable earnings after Th...

CRISPR Therapeutics (NASDAQ: CRSP) and Fulgent Genetics (NASDAQ: FLGT) operate at different ends of the scientific gene pool. CRISPR, named for the Nobel Prize-winning CRISPR gene-editing technique, is a clinical-stage biotech company that is looking for gene-editing therapi...

Cases of, hospitalizations for, and deaths attributable to COVID-19 are finally dropping significantly. That's fantastic news for society at large, but it means the makers of coronavirus tests are going to see the eye-popping growth rates they put up in 2020 turn negative. Many are already ...

Moderna (NASDAQ: MRNA) , Teladoc Health (NYSE: TDOC) and Fulgent Genetics (NASDAQ: FLGT) have all had incredible runs over the last year. Moderna is up 570%. Teladoc stock has jumped 127%. And Fulgent has run up 500%. What's the strongest stock? Healthcare and Cannab...